Clemensen Steenberg (maidburn95)

ed platforms were standardized for reference samples, their use is recommended for the measurement of CSF AD biomarkers compared with unstandardized manual methods, such as Innotest ELISA, that have demonstrated a high inter and intra-laboratory variability.Background Behavioral and psychological symptoms of dementia (BPSD) are a distressful condition. We aimed to investigate the BPSD distribution in subjects with cognitive impairment, and the potential correlations between BPSD and neurodegeneration in terms of cerebrospinal fluid (CSF) tau and brain atrophy. Methods One-hundred patients with mild cognitive impairment (MCI) or dementia (Alzheimer's disease, AD; Lewy-body disease, LBD; frontotemporal dementia, FTD; vascular dementia, VD) underwent a complete diagnostic workup, including 3T-MRI and/or CT and CSF. Cortical atrophy was assessed with medial temporal atrophy (MTA), posterior atrophy (PA), and global cortical atrophy-frontal lobe (GCA-F) scales. BPSD were rated using the Neuropsychiatric Inventory (NPI), and BPSD clusters were defined according to the European Alzheimer Disease Consortium. Results Delusions, hallucinations, and psychosis cluster were differently distributed among the diagnostic groups (p less then 0.05, p less then 0.001, and p lssociated with the occurrence and severity of BPSD in clinical practice. Longitudinal studies are however required to ascertain their actual predictive value.This review summarizes our current knowledge of human disease-relevant genetic variants within the family of voltage gated Ca2+ channels. Ca2+ channelopathies cover a wide spectrum of diseases including epilepsies, autism spectrum disorders, intellectual disabilities, developmental delay, cerebellar ataxias and degeneration, severe cardiac arrhythmias, sudden cardiac death, eye disease and endocrine disorders such as congential hyperinsulinism and hyperaldosteronism. A special focus will be on the rapidly increasing number of de novo missense mutations identified in the pore-forming α1-subunits with next generation sequencing studies of well-defined patient cohorts. In contrast to likely gene disrupting mutations these can not only cause a channel loss-of-function but can also induce typical functional changes permitting enhanced channel activity and Ca2+ signaling. Such gain-of-function mutations could represent therapeutic targets for mutation-specific therapy of Ca2+-channelopathies with existing or novel Ca2+-channel inhibitors. Moreover, many pathogenic mutations affect positive charges in the voltage sensors with the potential to form gating-pore currents through voltage sensors. If confirmed in functional studies, specific blockers of gating-pore currents could also be of therapeutic interest.Occlusions, restricted field of view and limited resolution all constrain a robot's ability to sense its environment from a single observation. In these cases, the robot first needs to actively query multiple observations and accumulate information before it can complete a task. In this paper, we cast this problem of active vision as active inference, which states that an intelligent agent maintains a generative model of its environment and acts in order to minimize its surprise, or expected free energy according to this model. We apply this to an object-reaching task for a 7-DOF robotic manipulator with an in-hand camera to scan the workspace. A novel generative model using deep neural networks is proposed that is able to fuse multiple views into an abstract representation and is trained from data by minimizing variational free energy. We validate our approach experimentally for a reaching task in simulation in which a robotic agent starts without any knowledge about its workspace. Each step, the next view pose is chosen by evaluating the expected free energy. We find that by minimizing the expected free energy, exploratory behavior emerges when the target object to reach is not in view, and the end effector is moved to t